&nbsp;

Waiting Room Slides & Screen Savers - Other Languages.zip

May 2023

Document

no-harm.png

Sep 2024

Drug

nivolumab / relatlimab

Other Name(s): Opdualag™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Feb 2025

Document

Why-Biosimilars-are-Sold-in-Canada.png

Jan 2025

Document

What-to-Expect-When-Taking-a-Biosimilar.png

Jan 2025

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

May 2025

Drug

niraparib / abiraterone

Other Name(s): Akeega™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Sep 2025

Regimen

NIVL+IPIL

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Drugs Used:

nivolumab (Compassionate),

ipilimumab (Compassionate)

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

NIVL(MNT)

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Drugs Used:

nivolumab (Unfunded)

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

NIVL+RELA

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab and Relatlimab - Advanced Melanoma (Unresectable or Metastatic Melanoma)

Drugs Used:

nivolumab / relatlimab